Natural Product (NP) Details
General Information of the NP (ID: NP1489) | |||||
---|---|---|---|---|---|
Name |
Tropisetron
|
||||
Synonyms |
tropisetron; 89565-68-4; Tropisetronum; Tropisteron; [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 1H-indole-3-carboxylate; UNII-6I819NIK1W; Novaban; ICS 205930; (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 1H-indole-3-carboxylate; Navoban (TN); ICF 205-930; CHEMBL56564; beta-Tropisetron; 6I819NIK1W; CHEBI:32269; Tropisetron (INN); DSSTox_CID_24137; DSSTox_RID_80108; DSSTox_GSID_44137; 1alphaH,5alphaH-Tropan-3alpha-yl indole-3-carboxylate; 1H-indole-3-carboxylic acid [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] ester; TKT; Lopac-T-104; CAS-89565-68-4; Tropisetron [INN:BAN]; ICS-205930; Tropisetronum [INN-Latin]; NCGC00015984-03; ICS-205-930; SCHEMBL18297; SCHEMBL18298; SCHEMBL18299; GTPL260; ics205-930; SCHEMBL3953452; CHEMBL1289230; DTXSID2044137; SCHEMBL13287285; CHEBI:94647; HMS2090D16; HMS3886M10; HY-B0072; Tox21_110272; BDBM50108392; PDSP1_000776; PDSP2_000764; s5538; ZINC18130447; AKOS015969677; Tox21_110272_1; ZINC100019233; ZINC100023360; CCG-267308; CS-1146; DB11699; 1H-Indole-3-carboxylic acid, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-; NCGC00015984-01; NCGC00015984-04; NCGC00161414-01; NCGC00161414-03; NCGC00390718-01; H833; C13666; D02130; Q29428; W-5128; AB00698553-07; AB00698553-09; 565T684; BRD-K50866992-003-09-5; BRD-K50866992-003-10-3; Q27166461; 1H-Indole-3-carboxylic acid (1R,5S)-8-methyl-8-azabicyclo[3.2.1]octane-3-yl ester
Click to Show/Hide
|
||||
Species Origin | Homo sapiens ... | Click to Show/Hide | |||
Homo sapiens | |||||
Disease | Pain [ICD-11: MG30-MG3Z] | Approved | [1] | ||
Structure |
![]() |
Click to Download Mol2D MOL |
|||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C17H20N2O2
|
||||
PubChem CID | |||||
Canonical SMILES |
CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43
|
||||
InChI |
1S/C17H20N2O2/c1-19-11-6-7-12(19)9-13(8-11)21-17(20)15-10-18-16-5-3-2-4-14(15)16/h2-5,10-13,18H,6-9H2,1H3/t11-,12+,13?
|
||||
InChIKey |
ZNRGQMMCGHDTEI-FUNVUKJBSA-N
|
||||
CAS Number |
CAS 89565-68-4
|
||||
ChEBI ID | |||||
TTD Drug ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Fluvoxamine | Depression | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
Biological
Regulation |
Down-regulation | 5-HT content | ||||
In-vivo Model | Clinical Trial | |||||
Experimental
Result(s) |
This trial showed a significant efficacy for tropisetron over placebo in treatment of obsessive-compulsive disorder symptoms when added to fluvoxamine. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Serotonin receptor 3A (HTR3A) | Molecule Info | [3] | |
KEGG Pathway | Serotonergic synapse | Click to Show/Hide | ||
NetPath Pathway | IL2 Signaling Pathway | Click to Show/Hide | ||
Panther Pathway | 5HT3 type receptor mediated signaling pathway | Click to Show/Hide | ||
Reactome | Ligand-gated ion channel transport | Click to Show/Hide | ||
WikiPathways | SIDS Susceptibility Pathways | Click to Show/Hide | ||
2 | Iron uptake and transport |
